SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+130.12%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$355M
AUM Growth
+$355M
(+59%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
41.98%
Top 10 Holdings %
Top 10 Hldgs %
59.98%
Holding
61
New
22
Increased
9
Reduced
5
Closed
9
Top Buys
| 1 |
Icon
ICLR
|
$41M |
| 2 |
Cigna
CI
|
$19.7M |
| 3 |
Sanofi
SNY
|
$18.7M |
| 4 |
Maximus
MMS
|
$16.9M |
| 5 |
DRUG
Bright Minds Biosciences
DRUG
|
$16.3M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$24.3M |
| 2 |
Labcorp
LH
|
$13.8M |
| 3 |
Kenvue
KVUE
|
$11M |
| 4 |
Biodesix
BDSX
|
$7.72M |
| 5 |
Disc Medicine
IRON
|
$7.25M |
Sector Composition
| 1 | Healthcare | 91.96% |
| 2 | Industrials | 8.01% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ironwood Pharmaceuticals
IRWD
$201M
| $4.02M | 1.13% |
+907,783
| New | +$4.02M |
|
27
Artivion
AORT
$2.04B
| $3.46M | 0.97% |
121,178
| – | – |
|
28
Erasca
ERAS
$406M
| $3.4M | 0.96% |
1,356,186
-863,000
| -39% | -$2.17M |
|
29
Tyra Biosciences
TYRA
$657M
| $3.35M | 0.94% |
240,870
-160,000
| -40% | -$2.22M |
|
30
IDEAYA Biosciences
IDYA
$2.26B
| $3.16M | 0.89% |
123,000
| – | – |
|
|
ACOG
31
Alpha Cognition Inc. Common Stock
ACOG
$132M
| $2.56M | 0.72% |
+434,700
| New | +$2.56M |
|
32
Q32 Bio
QTTB
$20.9M
| $2.4M | 0.68% |
+697,413
| New | +$2.4M |
|
33
TELA Bio
TELA
$65.4M
| $1.9M | 0.54% |
+630,000
| New | +$1.9M |
|
34
Nuvation Bio
NUVB
$1.08B
| $1.78M | 0.5% |
668,115
| – | – |
|
35
Context Therapeutics
CNTX
$75.6M
| $1.39M | 0.39% |
1,328,352
| – | – |
|
36
Alector
ALEC
$282M
| $1.16M | 0.33% |
+615,628
| New | +$1.16M |
|
37
Enanta Pharmaceuticals
ENTA
$189M
| $1.02M | 0.29% |
177,004
| – | – |
|
38
Ovid Therapeutics
OVID
$94.6M
| $934K | 0.26% |
+1,000,000
| New | +$934K |
|
39
Aprea Therapeutics
APRE
$8.91M
| $910K | 0.26% |
276,603
| – | – |
|
40
Foghorn Therapeutics
FHTX
$298M
| $574K | 0.16% |
121,672
| – | – |
|
41
C4 Therapeutics
CCCC
$182M
| $558K | 0.16% |
+155,000
| New | +$558K |
|
42
Avalo Therapeutics
AVTX
$139M
| $531K | 0.15% |
71,458
| – | – |
|
|
BOLD
43
Boundless Bio
BOLD
$25.7M
| $470K | 0.13% |
162,058
| – | – |
|
|
NYXH
44
Nyxoah
NYXH
$220M
| $407K | 0.11% |
50,839
| – | – |
|
45
Modular Medical
MODD
$39.7M
| $345K | 0.1% |
251,990
+131,218
| +109% | +$180K |
|
|
MESO
46
Mesoblast
MESO
$1.65B
| $230K | 0.06% |
+11,600
| New | +$230K |
|
47
NextCure
NXTC
$13.3M
| $100K | 0.03% |
130,000
| – | – |
|
48
Humacyte, Inc. Warrant
HUMAW
$32.6M
| $91.7K | 0.03% |
49,998
| – | – |
|
49
Terns Pharmaceuticals
TERN
$651M
| $55.4K | 0.02% |
10,000
| – | – |
|
50
Rocket Pharmaceuticals, Inc. Warrant
RCKTW
$4.17M
| $15.4K | ﹤0.01% |
400,000
| – | – |
|